Indications
Treatment of primary apnoea of premature newborns.
Composition
- Active substance
- Caffeine citrate
- International name (INN)
- caffeine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Peyona (previously Nymusa)
- Active substance
- Caffeine citrate
- ATC code
- N06BC01
- Group
- Nervous system
- Therapeutic area
- Apnea
- Marketing authorisation holder
- Chiesi Farmaceutici SpA
- Status
- Authorised
- EU authorisation
- 2 Jul 2009